# Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

> **NCT01634880** · PHASE2 · WITHDRAWN · sponsor: **Athanassios Argiris**

## Conditions studied

- Salivary Gland Malignancy

## Interventions

- **DRUG:** Postoperative Radiotherapy and Panitumumab

## Key facts

- **NCT ID:** NCT01634880
- **Lead sponsor:** Athanassios Argiris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of accrual.
- **Last updated:** 2016-05-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01634880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01634880, "Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01634880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*